ProPhase Labs, Inc. (NASDAQ:PRPH – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $0.08 and traded as low as $0.0083. ProPhase Labs shares last traded at $0.0101, with a volume of 197,081 shares trading hands.
ProPhase Labs Stock Down 0.8%
The firm’s 50 day moving average is $0.03 and its two-hundred day moving average is $0.07. The firm has a market cap of $217,440.00, a P/E ratio of -0.01 and a beta of 0.06. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.14.
ProPhase Labs Company Profile
ProPhase Labs, Inc is a diversified health and wellness company focused on diagnostics, genomics, consumer healthcare products and related biopharmaceutical opportunities. The company operates through businesses that develop and commercialize products and services intended to support disease detection, personalized health information and consumer wellness.
Its consumer healthcare operations include Cold-EEZE zinc-based products, which are marketed in forms such as lozenges and oral sprays for common-cold symptom support.
See Also
- Five stocks we like better than ProPhase Labs
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.
